Protective effect of recombinant human brain natriuretic peptide against contrast-induced nephropathy in elderly acute myocardial infarction patients: A randomized controlled trial

doi:10.12998/wjcc.v10.i33.12221

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 33

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2964)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

140

WORD

HTML

1347

Figures (1-2)

347

Tables (1-3)

310

Sum=2170

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

211

Download

583

Sum=794

Nov 26, 2022 (publication date) through Dec 18, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Controlled Trial

World J Clin Cases. Nov 26, 2022; 10(33): 12221-12229
Published online Nov 26, 2022. doi: 10.12998/wjcc.v10.i33.12221

Table 3 Clinical outcomes and complications in the two groups, n (%)

	Placebo	rhBNP	P value
Cardiogenic death	6 (9.1)	5 (7.7)	0.773
Recurrent myocardial infarction	3 (4.5)	3 (1.5)	1.000
Acute heart failure	15 (22.7)	5 (7.7)	0.017
CIN	14 (21.2)	5 (9.2)	0.028

CIN: Contrast-induced nephropathy; rhBNP: Recombinant human brain natriuretic peptide.

Citation: Zhang YJ, Yin L, Li J. Protective effect of recombinant human brain natriuretic peptide against contrast-induced nephropathy in elderly acute myocardial infarction patients: A randomized controlled trial. World J Clin Cases 2022; 10(33): 12221-12229
URL: https://www.wjgnet.com/2307-8960/full/v10/i33/12221.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i33.12221